Edition:
United States

Atossa Genetics Inc (ATOS.OQ)

ATOS.OQ on NASDAQ Stock Exchange Capital Market

2.31USD
16 Aug 2018
Change (% chg)

-- (--)
Prev Close
$2.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
45,993
52-wk High
$18.96
52-wk Low
$2.03

Latest Key Developments (Source: Significant Developments)

Atossa Genetics Receives Positive Interim Safety Review In Phase 1 Topical Endoxifen Dose Escalation Study
Tuesday, 15 May 2018 08:00am EDT 

May 15 (Reuters) - Atossa Genetics Inc ::ATOSSA GENETICS RECEIVES POSITIVE INTERIM SAFETY REVIEW FROM INDEPENDENT SAFETY COMMITTEE IN PHASE 1 TOPICAL ENDOXIFEN DOSE ESCALATION STUDY IN MEN.ATOSSA GENETICS INC - INDEPENDENT SAFETY COMMITTEE REVIEWED BLINDED DATA CONCLUDED STUDY MAY ADVANCE TO FINAL DOSING LEVEL.  Full Article

Atossa Genetics Announces Quarterly Loss Per Share $0.71
Monday, 14 May 2018 08:00am EDT 

May 14 (Reuters) - Atossa Genetics Inc ::ATOSSA GENETICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE.ATOSSA GENETICS INC QUARTERLY LOSS PER SHARE $0.71.  Full Article

Atossa Genetics Announces 2017 Financial Results
Thursday, 8 Mar 2018 04:05pm EST 

March 8 (Reuters) - Atossa Genetics Inc ::ATOSSA GENETICS ANNOUNCES 2017 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE.  Full Article

Atossa Genetics posts Q3 loss per share ‍$0.18​
Tuesday, 14 Nov 2017 08:00am EST 

Nov 14 (Reuters) - Atossa Genetics Inc :Atossa Genetics announces third quarter 2017 financial results and provides company update.Atossa Genetics Inc qtrly loss per share ‍$0.18​.  Full Article

L1 Capital Global Opportunities Master Fund reports 9.01 pct passive stake in ‍atossa Genetics, as of Oct. 26
Friday, 3 Nov 2017 05:25pm EDT 

Nov 3 (Reuters) - L1 Capital Global Opportunities Master Fund Ltd: :L1 capital global opportunities master fund ltd reports 9.01% passive stake in ‍atossa genetics inc, as of october 26, 2017 - SEC filing‍​.  Full Article

Empery Asset Management reports 9.01 pct passive stake in Atossa Genetics
Tuesday, 31 Oct 2017 03:02pm EDT 

Oct 31 (Reuters) - Empery Asset Management LP::Empery Asset Management LP reports 9.01 percent passive stake in Atossa Genetics as of Oct 26 - SEC filing‍​.  Full Article

Atossa Genetics announces pricing of $5.1 million public offering
Thursday, 26 Oct 2017 09:00am EDT 

Oct 26 (Reuters) - Atossa Genetics Inc :Atossa Genetics announces pricing of $5.1 million public offering of common stock.Says public offering of 11.5 million common shares priced at $0.44per share.  Full Article

Atossa Genetics announces proposed public offering of common stock
Wednesday, 25 Oct 2017 06:25pm EDT 

Oct 25 (Reuters) - Atossa Genetics Inc ::Atossa Genetics announces proposed public offering of common stock.Says ‍intends to offer and sell shares of its common stock in an underwritten public offering​.  Full Article

Atossa Genetics announces upcoming Phase 2 study of topical Endoxifen
Monday, 25 Sep 2017 08:00am EDT 

Sept 25 (Reuters) - Atossa Genetics Inc :Atossa Genetics announces upcoming Phase 2 study of topical Endoxifen.Atossa Genetics - ‍ Atossa plans to apply for approval from Institutional Review Board and Swedish regulatory authority within next 30 days​.  Full Article

Atossa Genetics files for mixed shelf of upto $50 million
Friday, 22 Sep 2017 04:46pm EDT 

Sept 23 (Reuters) - Atossa Genetics Inc :Atossa Genetics Inc files for mixed shelf of upto $50 million - SEC filing.‍​.  Full Article

BRIEF-Atossa Genetics Receives Positive Interim Safety Review In Phase 1 Topical Endoxifen Dose Escalation Study

* ATOSSA GENETICS RECEIVES POSITIVE INTERIM SAFETY REVIEW FROM INDEPENDENT SAFETY COMMITTEE IN PHASE 1 TOPICAL ENDOXIFEN DOSE ESCALATION STUDY IN MEN